"Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

We evaluated eculizumab, a complement protein C5 inhibitor, for treatment of severe COVID‐19 in pregnant and postpartum individuals. Click to show full abstract

We evaluated eculizumab, a complement protein C5 inhibitor, for treatment of severe COVID‐19 in pregnant and postpartum individuals.

Keywords: eculizumab treatment; complement; blockade eculizumab; complement blockade; treatment severe

Journal Title: American Journal of Reproductive Immunology
Year Published: 2022

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended